e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Cystic fibrosis: new basic, clinical and bacteriological knowledge
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prevalence and reservoirs of
A. xylosoxidans
and
S. maltophilia
in cystic fibrosis center
I. Asherova, S. Monachova, M. Ershova, S. Angelova (Yaroslavl, Russian Federation)
Source:
Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge
Session:
Cystic fibrosis: new basic, clinical and bacteriological knowledge
Session type:
Poster Discussion
Number:
4566
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Asherova, S. Monachova, M. Ershova, S. Angelova (Yaroslavl, Russian Federation). Prevalence and reservoirs of
A. xylosoxidans
and
S. maltophilia
in cystic fibrosis center. Eur Respir J 2011; 38: Suppl. 55, 4566
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Stenotrophomonas maltophilia
and
achromobacter xylosoxidans
in cystic fibrosis patients
Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies
Year: 2011
Audit of management of
pseudomonas aeruginosa
infection in children with cystic fibrosis
Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research
Year: 2009
Incidence and prevalence of non tuberculous mycobacteria [NTM] in adult CF population: A large adult CF centre experience
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Prevalence of renal impairment in an adult cystic fibrosis (CF) centre
Source: Eur Respir J 2005; 26: Suppl. 49, 622s
Year: 2005
Management of cystic fibrosis patients – The South Australian lung transplant satellite centre experience
Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Year: 2012
Cystic fibrosis: Heartburn and lung function – ²Too hot to handle²
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems
Year: 2012
Impact of sensitization to
Aspergillus fumigatus
on lung function in cystic fibrosis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010
Evolution of the infectious disease in cystic fibrosis (CF)
Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases
Year: 2008
The characteristics of the minimum inhibitory concentration of antibiotics on pulmonary infections in patients with cystic fibrosis
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
Improving identification and treatment of children & adolescents with cystic fibrosis related diabetes (CFRD)
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems
Year: 2012
Assessment of renal function in cystic fibrosis (CF) patients in R. Macedonia
Source: Eur Respir J 2007; 30: Suppl. 51, 387s
Year: 2007
Clinical features of adult’s cystic fibrosis in the Republic of Belarus
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
p.Leu206Trp mutation: Genotype-phenotype correlation in 23 paediatric / adults cystic fibrosis (CF) patients
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013
Cystic fibrosis
Source: Respipedia Article
Year: 2018
The effect of transition from a paediatric to adult cystic fibrosis (CF) centre on clinical status and hospital attendance
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016
Cystic fibrosis: prospects for therapy of some class 1 mutations
Source: Annual Congress 2007 - Cystic fibrosis: will the new biology deliver?
Year: 2007
Can
pseudomonas aeruginosa
infection change the outecome of bronchectasis?
Source: Annual Congress 2012 - Fungal, viral and other infections
Year: 2012
Familial idiopathic pulmonary fibrosis and "genetic anticipation"
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011
The spectrum of Nocardia lung disease in cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015
Does the cystic fibrosis phlegm feed the pseudomonas?
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept